INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $301,000 | -72.1% | 13,040 | -70.1% | 0.00% | -71.4% |
| Q4 2020 | $1,078,000 | -43.1% | 43,626 | -4.6% | 0.01% | -46.2% |
| Q3 2020 | $1,896,000 | +34.0% | 45,726 | +54.9% | 0.01% | +18.2% |
| Q2 2020 | $1,415,000 | +18.1% | 29,526 | +55.2% | 0.01% | 0.0% |
| Q1 2020 | $1,198,000 | -52.7% | 19,026 | -6.9% | 0.01% | -35.3% |
| Q4 2019 | $2,531,000 | +63.5% | 20,426 | -12.4% | 0.02% | +88.9% |
| Q3 2019 | $1,548,000 | -12.0% | 23,326 | +5.4% | 0.01% | -25.0% |
| Q2 2019 | $1,760,000 | +102.8% | 22,126 | +185.1% | 0.01% | +100.0% |
| Q1 2019 | $868,000 | +13.9% | 7,761 | +2.6% | 0.01% | 0.0% |
| Q4 2018 | $762,000 | -22.7% | 7,561 | -3.1% | 0.01% | -25.0% |
| Q3 2018 | $986,000 | – | 7,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |